Extension of the research development centre for cytostatic drugs (Q12109): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Created claim: summary (P836): The present project aims at expanding the R & D Centre for speeding up and improving the development of the final pharmaceutical form of cancer, both original and generic, built in the previous leges. a., Adding English summary)
(‎Changed an Item)
Property / programme
 
Property / programme: Enterprise and Innovation for Competitiveness - CZ - ERDF / rank
 
Normal rank

Revision as of 18:03, 25 March 2020

Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
Extension of the research development centre for cytostatic drugs
Project in Czech Republic financed by DG Regio

    Statements

    0 references
    5,007,500.0 Czech koruna
    0 references
    200,300.0 Euro
    10 January 2020
    0 references
    10,015,000.0 Czech koruna
    0 references
    400,600.0 Euro
    10 January 2020
    0 references
    50 percent
    0 references
    30 June 2020
    0 references
    VUAB Pharma a.s.
    0 references
    0 references

    50°9'46.91"N, 14°23'2.26"E
    0 references
    25263
    0 references
    Předkládaný projekt je zaměřen na rozšíření výzkumně-vývojového centra pro urychlení a zkvalitnění vývoje konečné lékové formy léčiv nádorových onemocnění, a to jak originálních, tak generických léčiv, které bylo vybudováno v předchozích letech. a. (Czech)
    0 references
    The present project aims at expanding the R & D Centre for speeding up and improving the development of the final pharmaceutical form of cancer, both original and generic, built in the previous leges. a. (English)
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/17_165/0015953
    0 references